文献速递肝胆胰外科围术期管理与 ERAS

腹腔镜与机器人远端胰腺切除术的成本效果与生活质量分析:倾向性评分匹配研究

Cost-effectiveness and quality of life analysis of laparoscopic and robotic distal pancreatectomy: a propensity score-matched study.
PubMed 文献 · Surg Endosc · 2020-04-02

本研究纳入2011至2017年接受腹腔镜或机器人远端胰腺切除术且术后随访至少12个月的患者,经1:2倾向性评分匹配后比较两组生活质量与成本效果。匹配后共103例(机器人组37例,腹腔镜组66例),机器人组在术后社会功能、恶心呕吐及经济状况等生活质量维度显著改善,但粗成本更高(12053欧元 vs. 5519欧元,P<0.001)。当支付意愿超过4800欧元/QALY时,机器人手术更具成本效果的概率更高。

要点

  • 机器人远端胰腺切除术在部分生活质量维度优于腹腔镜,但粗成本更高。
  • 机器人手术更具成本效果的概率在支付意愿超过4800欧元/QALY时更高。
  • 倾向性评分匹配后两组基线、术中、术后及病理变量无显著差异。

核心结论

  • 机器人远端胰腺切除术与特定生活质量维度改善相关,但粗成本高于腹腔镜手术。
  • 成本效果阈值为4800欧元/QALY,超过该支付意愿时机器人手术更具成本效果概率更高。

研究设计与样本

  • 回顾性队列研究,纳入2011至2017年接受腹腔镜或机器人远端胰腺切除术且术后随访至少12个月的患者。
  • 采用1:2倾向性评分匹配分析,最终纳入103例患者(机器人组37例,腹腔镜组66例)。
  • 使用EORTC QLQ-C30和EQ-5D问卷评估生活质量,计算平均差异成本和平均差异质量调整生命年(QALY)。

主要发现

  • 匹配后两组基线、术中、术后及病理变量无显著差异(p>0.05)。
  • 机器人组在术后社会功能(p=0.010)、恶心呕吐(p=0.050)和经济状况(p=0.030)维度显著改善。
  • 粗成本分析显示机器人手术比腹腔镜手术更昂贵(12053欧元 vs. 5519欧元,p<0.001)。
  • 当支付意愿超过4800欧元/QALY时,机器人手术更具成本效果的概率更高。

关键数值与推荐

  • 成本效果阈值为4800欧元/QALY。
  • 机器人组粗成本12053欧元,腹腔镜组5519欧元(p<0.001)。
  • 生活质量显著改善维度:社会功能(p=0.010)、恶心呕吐(p=0.050)、经济状况(p=0.030)。

临床怎么用

  • 在支付意愿较高的医疗体系中,机器人远端胰腺切除术可能因生活质量改善而具有成本效果。
  • 临床决策需权衡机器人手术较高的粗成本与其在特定生活质量维度上的获益。

局限性

  • 原文未报告局限性相关内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study analyzed the Quality of Life (QoL) and cost-effectiveness of laparoscopic (LDP) versus robotic distal pancreatectomy (RDP). METHOD: All patients who underwent LDP or RDP from 2011 to 2017 and with a minimum postoperative follow-up of 12 months were included in the study. To minimize bias, a propensity score-matched analysis (1:2) was performed. Two different questionnaires (EORTC QLQ-C30 and EQ-5D) were completed by the patients. The mean differential cost and mean differential Quality Adjusted Life Years (QALY) were calculated and plotted on a cost-utility plane. RESULTS: The study population consisted of 152 patients. After having applied the propensity score matching, the final population included 103 patients divided into RDP group (n = 37, 36%) and LDP (n = 66, 64%). No differences were found between groups regarding the baseline, intraoperative, postoperative, and pathological variables (p > 0.05). The QoL analysis showed a significant improvement in the RDP group on the postoperative social function, nausea, vomiting, and financial status (p = 0.010, p = 0.050, and p = 0.030, respectively). As expected, the crude costs analysis confirmed that RDP was more expensive than LDP (12,053 Euros vs. 5519 Euros, p < 0.001). However, the robotic approach had a higher probability of being more cost-effective than the laparoscopic procedure when a willingness to pay of more than 4800 Euros/QALY was accepted. CONCLUSION: RDP was associated with QoL improvement in specific domains. Crude costs were higher relative to LDP. Cost-effectiveness threshold resulted to be 4800 euros/QALY. The increasing worldwide diffusion of the robotic technology, with easier access and possible cost reduction, could increase the sustainability of this procedure.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. De Pastena M, Esposito A, Paiella S, et al. Cost-effectiveness and quality of life analysis of laparoscopic and robotic distal pancreatectomy: a propensity score-matched study. Surg Endosc. 2020. PMID: 32240383. doi:10.1007/s00464-020-07528-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。